ADVISORY/California Healthcare Institute and PricewaterhouseCoopers to Issue Report on Southern California's Biomedical Industry.Business Editors & Health/Medical Writers BIOWIRE2K ADVISORY...for Thursday (Feb. 21) LA JOLLA La Jolla (lə hoi`yə), on the Pacific Ocean, S Calif., an uninc. district within the confines of San Diego; founded 1869. The beautiful ocean beaches, in particular La Jolla shores and Black's Beach, and sea-washed caves attract visitors and , Calif.--(BW HealthWire)--Feb. 20, 2002 California Healthcare Institute (CHI (Computer Human Interface) Typically refers to the devices and associated applications used by humans to interact with computers. For example, a CICS data entry screen displayed on a 3270 terminal makes up a CHI for a banking application. ) and PricewaterhouseCoopers will release the results of a new study on the economic contributions of the biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. industry in Southern California Southern California, also colloquially known as SoCal, is the southern portion of the U.S. state of California. Centered on the cities of Los Angeles and San Diego, Southern California is home to nearly 24 million people and is the nation's second most populated region, at a luncheon forum on Thursday, February 21 at City of Hope National Medical Center City of Hope is one of 39 NCI-designated Cancer Centers and is located in the city of Duarte, California. City of Hope comprises an ambulatory and in-patient cancer treatment center as well as a biomedical research facility known as the Beckman Research Institute and the City of Hope in Duarte, Calif. The study showcases the importance of medical and biomedical research Biomedical research (or experimental medicine), in general simply known as medical research, is the basic research or applied research conducted to aid the body of knowledge in the field of medicine. , development, and manufacturing to Southern California's economy and ultimately, to the nation's health. It includes new information on employment, salaries, R&D investment, product development, trade and recent medical advances by biomedical companies and leading universities in Southern California.
WHAT: Southern California Biomedical Industry Economic Study to
be Issued
WHEN: Thursday, Feb. 21, 2002
11:30 a.m. - 1:30 p.m.
Luncheon
WHERE: City of Hope National Medical Center
1500 E. Duarte Road
Duarte, Calif.
WHO: -- David Gollaher, Ph.D., President & CEO, CHI
-- Geoff Barnett, Partner, Life Sciences Industry Services,
PricewaterhouseCoopers LLP
-- Larry Couture, Ph.D., Senior Vice President, Center for
Biomedicine & Genetics, City of Hope
-- Fabrizio Bonanni, Dr. Chem., Senior Vice President,
Quality & Compliance, Amgen
-- Anna Richo, Associate General Counsel, Baxter BioScience
If you would like to attend, please contact Taylor Mayo at City of Hope, 626/301-8217 or tmayo@coh.org. |
|
|||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion